Cargando…
Autophagy inhibition enhances PD-L1 expression in gastric cancer
BACKGROUND: Autophagy, a process for degrading intracellular substances to maintain basal metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 (PD-1) with its ligand (PD-L1) are important immune checkpoint proteins and their regulation by autophagy has been reporte...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440013/ https://www.ncbi.nlm.nih.gov/pubmed/30925913 http://dx.doi.org/10.1186/s13046-019-1148-5 |
_version_ | 1783407311670214656 |
---|---|
author | Wang, Xiaojuan Wu, William K. K. Gao, Jing Li, Zhongwu Dong, Bin Lin, Xiaoting Li, Yilin Li, Yanyan Gong, Jifang Qi, Changsong Peng, Zhi Yu, Jun Shen, Lin |
author_facet | Wang, Xiaojuan Wu, William K. K. Gao, Jing Li, Zhongwu Dong, Bin Lin, Xiaoting Li, Yilin Li, Yanyan Gong, Jifang Qi, Changsong Peng, Zhi Yu, Jun Shen, Lin |
author_sort | Wang, Xiaojuan |
collection | PubMed |
description | BACKGROUND: Autophagy, a process for degrading intracellular substances to maintain basal metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 (PD-1) with its ligand (PD-L1) are important immune checkpoint proteins and their regulation by autophagy has been reported in mouse melanoma and human ovarian cancer. Here, we explored the interplay between autophagy and the PD1/PD-L1 axis in gastric cancer. METHODS: The expression of PD-L1 in gastric cancer cells was detected by Western blot and flow cytometry analysis. The effect of autophagy inhibition on PD-L1 expression was examined in vitro and in vivo. The molecular mechanisms of the regulation of PD-L1 by autophagy were evaluated in gastric cancer cell lines. The clinical relevance of autophagy-related markers p62/SQSTM1 and LC3 with PD-L1 was evaluated in 137 patients with gastric cancer. RESULTS: We found that inhibition of autophagy by pharmacological inhibitors or small interfering RNAs increased the levels of PD-L1 in cultured gastric cancer cells and in xenografts. Interferon (IFN)-γ also promoted PD-L1 gene transcription, whose action was enhanced by autophagy inhibition. Mechanistically, autophagy inhibition led to the accumulation of p62/SQSTM1 and activation of nuclear factor (NF)-κB, in which NF-κB inhibition or p62/SQSTM1 knockdown attenuated PD-L1 induction by autophagy inhibition. Immunohistochemical staining of primary tumor tissues of 137 patients with gastric cancer showed that LC3 and p62/SQSTM1 protein levels were positively correlated with PD-L1 (LC3, p < 0.001; p62/SQSTM1, p < 0.05). The expression of PD-L1 was also positively correlated with tumor lymphocyte infiltration (p < 0.001). CONCLUSIONS: We discovered that autophagy regulates PD-L1 expression in gastric cancer through the p62/SQSTM1-NF-κB pathway. Pharmacological modulation of autophagy may thus influence the therapeutic efficacy of PD-L1 blockade in gastric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1148-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6440013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64400132019-04-11 Autophagy inhibition enhances PD-L1 expression in gastric cancer Wang, Xiaojuan Wu, William K. K. Gao, Jing Li, Zhongwu Dong, Bin Lin, Xiaoting Li, Yilin Li, Yanyan Gong, Jifang Qi, Changsong Peng, Zhi Yu, Jun Shen, Lin J Exp Clin Cancer Res Research BACKGROUND: Autophagy, a process for degrading intracellular substances to maintain basal metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 (PD-1) with its ligand (PD-L1) are important immune checkpoint proteins and their regulation by autophagy has been reported in mouse melanoma and human ovarian cancer. Here, we explored the interplay between autophagy and the PD1/PD-L1 axis in gastric cancer. METHODS: The expression of PD-L1 in gastric cancer cells was detected by Western blot and flow cytometry analysis. The effect of autophagy inhibition on PD-L1 expression was examined in vitro and in vivo. The molecular mechanisms of the regulation of PD-L1 by autophagy were evaluated in gastric cancer cell lines. The clinical relevance of autophagy-related markers p62/SQSTM1 and LC3 with PD-L1 was evaluated in 137 patients with gastric cancer. RESULTS: We found that inhibition of autophagy by pharmacological inhibitors or small interfering RNAs increased the levels of PD-L1 in cultured gastric cancer cells and in xenografts. Interferon (IFN)-γ also promoted PD-L1 gene transcription, whose action was enhanced by autophagy inhibition. Mechanistically, autophagy inhibition led to the accumulation of p62/SQSTM1 and activation of nuclear factor (NF)-κB, in which NF-κB inhibition or p62/SQSTM1 knockdown attenuated PD-L1 induction by autophagy inhibition. Immunohistochemical staining of primary tumor tissues of 137 patients with gastric cancer showed that LC3 and p62/SQSTM1 protein levels were positively correlated with PD-L1 (LC3, p < 0.001; p62/SQSTM1, p < 0.05). The expression of PD-L1 was also positively correlated with tumor lymphocyte infiltration (p < 0.001). CONCLUSIONS: We discovered that autophagy regulates PD-L1 expression in gastric cancer through the p62/SQSTM1-NF-κB pathway. Pharmacological modulation of autophagy may thus influence the therapeutic efficacy of PD-L1 blockade in gastric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1148-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-29 /pmc/articles/PMC6440013/ /pubmed/30925913 http://dx.doi.org/10.1186/s13046-019-1148-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wang, Xiaojuan Wu, William K. K. Gao, Jing Li, Zhongwu Dong, Bin Lin, Xiaoting Li, Yilin Li, Yanyan Gong, Jifang Qi, Changsong Peng, Zhi Yu, Jun Shen, Lin Autophagy inhibition enhances PD-L1 expression in gastric cancer |
title | Autophagy inhibition enhances PD-L1 expression in gastric cancer |
title_full | Autophagy inhibition enhances PD-L1 expression in gastric cancer |
title_fullStr | Autophagy inhibition enhances PD-L1 expression in gastric cancer |
title_full_unstemmed | Autophagy inhibition enhances PD-L1 expression in gastric cancer |
title_short | Autophagy inhibition enhances PD-L1 expression in gastric cancer |
title_sort | autophagy inhibition enhances pd-l1 expression in gastric cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440013/ https://www.ncbi.nlm.nih.gov/pubmed/30925913 http://dx.doi.org/10.1186/s13046-019-1148-5 |
work_keys_str_mv | AT wangxiaojuan autophagyinhibitionenhancespdl1expressioningastriccancer AT wuwilliamkk autophagyinhibitionenhancespdl1expressioningastriccancer AT gaojing autophagyinhibitionenhancespdl1expressioningastriccancer AT lizhongwu autophagyinhibitionenhancespdl1expressioningastriccancer AT dongbin autophagyinhibitionenhancespdl1expressioningastriccancer AT linxiaoting autophagyinhibitionenhancespdl1expressioningastriccancer AT liyilin autophagyinhibitionenhancespdl1expressioningastriccancer AT liyanyan autophagyinhibitionenhancespdl1expressioningastriccancer AT gongjifang autophagyinhibitionenhancespdl1expressioningastriccancer AT qichangsong autophagyinhibitionenhancespdl1expressioningastriccancer AT pengzhi autophagyinhibitionenhancespdl1expressioningastriccancer AT yujun autophagyinhibitionenhancespdl1expressioningastriccancer AT shenlin autophagyinhibitionenhancespdl1expressioningastriccancer |